Phase I Study of IMP321 Given Alone or as an Adjuvant to a Reference Flu Antigen
Clinical trial NCT00354263 · COMPLETED
Trial details
- NCT number
- NCT00354263
- Sponsor
- Immutep S.A.S.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2005-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.